Perspectives Series: Molecular Medicine in Genetically Engineered Animals
暂无分享,去创建一个
K. Rajewsky | J. Roes | Werner Müller | H. Gu | Ralf Kühn | F. Schwenk | Werner Müller
[1] K. Rajewsky,et al. Aberrant B Cell Development and Immune Response in Mice with a Compromised BCR Complex , 1996, Science.
[2] J. Heath,et al. Cardiotrophin-1 Activates a Distinct Form of Cardiac Muscle Cell Hypertrophy , 1996, The Journal of Biological Chemistry.
[3] R. Evans,et al. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[4] P. Angrand,et al. Regulation of Cre recombinase activity by the synthetic steroid RU 486. , 1996, Nucleic acids research.
[5] U. Certa,et al. Efficient control of gene expression by single step integration of the tetracycline system in transgenic mice , 1996, Nature Biotechnology.
[6] K. Chien,et al. Cardiotrophin-1 displays early expression in the murine heart tube and promotes cardiac myocyte survival. , 1996, Development.
[7] F. Sablitzky,et al. Inducible site-directed recombination in mouse embryonic stem cells. , 1996, Nucleic acids research.
[8] L. Tabak,et al. T-cell-specific deletion of a polypeptide N-acetylgalactosaminyl-transferase gene by site-directed recombination. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[9] A. Bradley,et al. Chromosome engineering in mice , 1995, Nature.
[10] J. Wilson,et al. Gene therapy for cystic fibrosis: challenges and future directions. , 1995, The Journal of clinical investigation.
[11] D. Rader,et al. A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia , 1995, Nature Medicine.
[12] S. Rosenberg,et al. T Lymphocyte-Directed Gene Therapy for ADA− SCID: Initial Trial Results After 4 Years , 1995, Science.
[13] L. Zon,et al. Developmental biology of hematopoiesis. , 1995, Blood.
[14] S. Orkin,et al. Transcription factor GATA-1 permits survival and maturation of erythroid precursors by preventing apoptosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[15] D. Steinberg,et al. Effect of the antioxidant N,N'-diphenyl 1,4-phenylenediamine (DPPD) on atherosclerosis in apoE-deficient mice. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[16] K. Weinberg,et al. Engraftment of gene–modified umbilical cord blood cells in neonates with adenosine deaminase deficiency , 1995, Nature Medicine.
[17] K. Chien,et al. Ventricular Expression of a MLC-2v-ras Fusion Gene Induces Cardiac Hypertrophy and Selective Diastolic Dysfunction in Transgenic Mice (*) , 1995, The Journal of Biological Chemistry.
[18] M. Moskowitz,et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase , 1995, Nature.
[19] M Aguet,et al. Inducible gene targeting in mice , 1995, Science.
[20] J. Taylor,et al. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[21] A. Joyner,et al. Rescue of the En-1 mutant phenotype by replacement of En-1 with En-2. , 1995, Science.
[22] R. Evans,et al. Retinoid-dependent pathways suppress myocardial cell hypertrophy. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[23] M. C. Lin,et al. Heart and lung disease in engineered mice , 1995, Nature Medicine.
[24] B. Abella,et al. Generation and characterization of a ΔF508 cystic fibrosis mouse model , 1995, Nature Genetics.
[25] Klaus Rajewsky,et al. Impairment of T-cell-dependent B-cell responses and B-l cell development in CD19-deficient mice , 1995, Nature.
[26] P. Chambon,et al. Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[27] S. Eaton,et al. Apical, basal, and lateral cues for epithelial polarization , 1995, Cell.
[28] Janet Rossant,et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.
[29] R. Nagai,et al. Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1. , 1995, The Journal of clinical investigation.
[30] A. Berns,et al. Adenosine–deaminase–deficient mice die perinatally and exhibit liver–cell degeneration, atelectasis and small intestinal cell death , 1995, Nature Genetics.
[31] M. Gossen,et al. Transcriptional activation by tetracyclines in mammalian cells. , 1995, Science.
[32] C. Logie,et al. Ligand-regulated site-specific recombination. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[33] I. Bernstein,et al. Generation of hematopoietic colony-forming cells from embryonic stem cells: synergy between a soluble factor from NIH-3T3 cells and hematopoietic growth factors. , 1995, Blood.
[34] M. Mehtali,et al. Human immunodeficiency virus type 1 infection of human CD4-transgenic rabbits. , 1995, The Journal of general virology.
[35] T. Kishimoto,et al. Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[36] J. Charles Jennette,et al. Malefemale differences in fertility and blood pressure in ACE-deficient mice , 1995, Nature.
[37] J. Gardin,et al. Echocardiographic assessment of left ventricular mass and systolic function in mice. , 1995, Circulation research.
[38] N. Cary,et al. TISSUE EXPRESSION OF HUMAN COMPLEMENT INHIBITOR, DECAY‐ACCELERATING FACTOR, IN TRANSGENIC PIGS A POTENTIAL APPROACH FOR PREVENTING XENOGRAFT REJECTION , 1995, Transplantation.
[39] J. Platt,et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury , 1995, Nature Medicine.
[40] M. Sanguinetti,et al. A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel , 1995, Cell.
[41] H. Ertl,et al. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses , 1995, Journal of virology.
[42] D. Gottlieb,et al. Embryonic stem cells express neuronal properties in vitro. , 1995, Developmental biology.
[43] D. Porteous,et al. Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens , 1995, Nature Genetics.
[44] H. S. Kim,et al. Genetic control of blood pressure and the angiotensinogen locus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[45] B L Langille,et al. Cardiac malformation in neonatal mice lacking connexin43. , 1995, Science.
[46] T. Kenakin,et al. Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the β2-adrenoceptor , 1995, Nature.
[47] E. Green,et al. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome , 1995, Cell.
[48] N. Sarvetnick,et al. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[49] K. Chien,et al. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[50] O. Smithies,et al. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension , 1995, Science.
[51] S. Orkin,et al. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL , 1995, Nature.
[52] S. Orkin,et al. Rescue of GATA-1-deficient embryonic stem cells by heterologous GATA-binding proteins , 1995, Molecular and cellular biology.
[53] A. Cumano,et al. Emergence of multipotent hemopoietic cells in the yolk sac and paraaortic splanchnopleura in mouse embryos, beginning at 8.5 days postcoitus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[54] M. Wiles,et al. Evidence for involvement of activin A and bone morphogenetic protein 4 in mammalian mesoderm and hematopoietic development , 1995, Molecular and cellular biology.
[55] J. Whitsett,et al. Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR. , 1994, Science.
[56] K. Rajewsky,et al. Cre-loxP-mediated gene replacement: a mouse strain producing humanized antibodies , 1994, Current Biology.
[57] L. Matis,et al. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[58] P. Nielsen,et al. In vitro generation of lymphoid precursors from embryonic stem cells. , 1994, The EMBO journal.
[59] R. Lefkowitz,et al. Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[60] M. Gossen,et al. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[61] J. Vonesch,et al. Genetic analysis of RXRα developmental function: Convergence of RXR and RAR signaling pathways in heart and eye morphogenesis , 1994, Cell.
[62] R. Crystal,et al. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis , 1994, Nature Genetics.
[63] T. Honjo,et al. Generation of lymphohematopoietic cells from embryonic stem cells in culture. , 1994, Science.
[64] E. Rubin,et al. Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. , 1994, The Journal of clinical investigation.
[65] H. Ertl,et al. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. , 1994, Immunity.
[66] M. Evans,et al. The Oncogenic Cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development , 1994, Cell.
[67] Robert A. Weinberg,et al. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1 , 1994, Nature Genetics.
[68] T. Braun,et al. ES-cells carrying two inactivated myf-5 alleles form skeletal muscle cells: activation of an alternative myf-5-independent differentiation pathway. , 1994, Developmental biology.
[69] A M Wobus,et al. Muscle cell differentiation of embryonic stem cells reflects myogenesis in vivo: developmentally regulated expression of myogenic determination genes and functional expression of ionic currents. , 1994, Developmental biology.
[70] James M. Wilson,et al. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis , 1994, Nature Genetics.
[71] K. Rajewsky,et al. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. , 1994, Science.
[72] Shylendra Kumar,et al. Milk composition and lactation of beta-casein-deficient mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[73] N. First,et al. Production of calves by transfer of nuclei from cultured inner cell mass cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[74] Christine E. Seidman,et al. α-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere , 1994, Cell.
[75] T. Honjo,et al. Lineage marker-negative lymphocyte precursors derived from embryonic stem cells in vitro differentiate into mature lymphocytes in vivo. , 1994, International immunology.
[76] G. Keller,et al. Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells. , 1994, Genes & development.
[77] D. Absher,et al. Gq- and ras-dependent pathways mediate hypertrophy of neonatal rat ventricular myocytes following alpha 1-adrenergic stimulation. , 1994, The Journal of biological chemistry.
[78] R. Evans,et al. RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. , 1994, Genes & development.
[79] M. Solomon,et al. Lipid composition of carcass tissue from transgenic pigs expressing a bovine growth hormone gene. , 1994, Journal of animal science.
[80] N. Copeland,et al. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. , 1994, Genes & development.
[81] D. Brenin,et al. Pluripotent embryonic stem cells from the rat are capable of producing chimeras. , 1994, Developmental biology.
[82] G. Johnson,et al. Magnetic resonance microscopy of mouse embryos. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[83] R. Lefkowitz,et al. Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. , 1994, Science.
[84] V. Ord,et al. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[85] James M. Wilson,et al. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia , 1994, Nature Genetics.
[86] J Ross,et al. Molecular and physiological alterations in murine ventricular dysfunction. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[87] R. Jaenisch,et al. Double replacement: strategy for efficient introduction of subtle mutations into the murine Col1a-1 gene by homologous recombination in embryonic stem cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[88] D. Ow,et al. Cre recombinase-mediated site-specific recombination between plant chromosomes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[89] R E Jacobs,et al. Magnetic resonance microscopy of embryonic cell lineages and movements. , 1994, Science.
[90] A. Schnieke,et al. Use of double-replacement gene targeting to replace the murine alpha-lactalbumin gene with its human counterpart in embryonic stem cells and mice , 1994, Molecular and cellular biology.
[91] M. Rudnicki,et al. MyoD or Myf-5 is required for the formation of skeletal muscle , 1993, Cell.
[92] G. Lyons,et al. In vitro chamber specification during embryonic stem cell cardiogenesis. Expression of the ventricular myosin light chain-2 gene is independent of heart tube formation. , 1993, The Journal of biological chemistry.
[93] A. Colman,et al. Transgenic Livestock as Bioreactors: Stable Expression of Human Alpha-1-Antitrypsin by a Flock of Sheep , 1993, Nature Biotechnology.
[94] L. Mullins,et al. Transgenesis in nonmurine species. , 1993, Hypertension.
[95] J. Breslow. Transgenic mouse models of lipoprotein metabolism and atherosclerosis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[96] S. Fazio. Recent insights into the pathogenesis of type III hyperlipoproteinemia. , 1993, Trends in cardiovascular medicine.
[97] R. Hammer,et al. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. , 1993, The Journal of clinical investigation.
[98] A. Müller,et al. ES cells have only a limited lymphopoietic potential after adoptive transfer into mouse recipients. , 1993, Development.
[99] A. Müller,et al. An early pre-liver intraembryonic source of CFU-S in the developing mouse , 1993, Nature.
[100] J. García-Porrero,et al. Para-aortic splanchnopleura from early mouse embryos contains B1a cell progenitors , 1993, Nature.
[101] K. Rajewsky,et al. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting , 1993, Cell.
[102] P. Howles,et al. Developmental analysis of tropomyosin gene expression in embryonic stem cells and mouse embryos , 1993, Molecular and cellular biology.
[103] T. Mcclanahan,et al. Hematopoietic growth factor receptor genes as markers of lineage commitment during in vitro development of hematopoietic cells [see comments] , 1993 .
[104] R. Frants,et al. Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia. , 1993, The Journal of biological chemistry.
[105] V. Stewart,et al. RAG-2-deficient blastocyst complementation: an assay of gene function in lymphocyte development. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[106] K. Chien. Molecular advances in cardiovascular biology. , 1993, Science.
[107] B. Sauer,et al. Genomic targeting with purified Cre recombinase. , 1993, Nucleic acids research.
[108] S. Nishikawa,et al. Expression and function of c-Kit in fetal hemopoietic progenitor cells: transition from the early c-Kit-independent to the late c-Kit-dependent wave of hemopoiesis in the murine embryo. , 1993, Development.
[109] K. Rajewsky,et al. Shutdown of class switch recombination by deletion of a switch region control element , 1993, Science.
[110] S. Powers,et al. HRas-dependent pathways can activate morphological and genetic markers of cardiac muscle cell hypertrophy. , 1993, The Journal of biological chemistry.
[111] M. Sands,et al. Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer , 1992, Nature.
[112] E. Rubin,et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.
[113] N. Maeda,et al. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. , 1992, Science.
[114] W. Risau,et al. Induction of vasculogenesis and hematopoiesis in vitro. , 1992, Development.
[115] J. Gutiérrez-Ramos,et al. In vitro differentiation of embryonic stem cells into lymphocyte precursors able to generate T and B lymphocytes in vivo. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[116] Wendy L. Kimber,et al. Cystic fibrosis in the mouse by targeted insertional mutagenesis , 1992, Nature.
[117] B. Birren,et al. Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[118] B. Koller,et al. An Animal Model for Cystic Fibrosis Made by Gene Targeting , 1992, Science.
[119] J. Marth,et al. Tissue- and site-specific DNA recombination in transgenic mice. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[120] L. Hennighausen,et al. Matrix-attachment regions can impart position-independent regulation of a tissue-specific gene in transgenic mice. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[121] B. Mosinger,et al. Targeted oncogene activation by site-specific recombination in transgenic mice. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[122] M. Gossen,et al. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[123] E. Ginns,et al. Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene , 1992, Nature.
[124] B. Hogan,et al. DVR-4 (bone morphogenetic protein-4) as a posterior-ventralizing factor in Xenopus mesoderm induction. , 1992, Development.
[125] J. Smith,et al. Bone morphogenetic protein 4: a ventralizing factor in early Xenopus development. , 1992, Development.
[126] G. Keller,et al. Rescue of erythroid development in gene targeted GATA–1− mouse embryonic stem cells , 1992, Nature Genetics.
[127] J. Seidman,et al. Production of homozygous mutant ES cells with a single targeting construct , 1992, Molecular and cellular biology.
[128] B. Sauer,et al. A positive selection vector for cloning high molecular weight DNA by the bacteriophage P1 system: improved cloning efficacy. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[129] M. Katsuki,et al. Overexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[130] B. Sauer,et al. Identification of cryptic lox sites in the yeast genome by selection for Cre-mediated chromosome translocations that confer multiple drug resistance. , 1992, Journal of molecular biology.
[131] V L Bautch,et al. Embryonic stem cell-derived cystic embryoid bodies form vascular channels: an in vitro model of blood vessel development. , 1992, Development.
[132] M. Perricaudet,et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium , 1992, Cell.
[133] J. Wilson,et al. Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits. , 1991, Science.
[134] T. Doetschman,et al. Myosin heavy chain gene expression in mouse embryoid bodies. An in vitro developmental study. , 1991, The Journal of biological chemistry.
[135] S. Schwartz,et al. Angioblast differentiation and morphogenesis of the vascular endothelium in the mouse embryo. , 1991, Developmental biology.
[136] J. Vitale,et al. Transgenic Production of a Variant of Human Tissue-Type Plasminogen Activator in Goat Milk: Generation of Transgenic Goats and Analysis of Expression , 1991, Bio/Technology.
[137] E. Wagner,et al. Early fetal hematopoietic development from in vitro differentiated embryonic stem cells. , 1991, The New biologist.
[138] A. Monaco,et al. Yeast artificial chromosome libraries containing large inserts from mouse and human DNA. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[139] H. Snodgrass,et al. Hematopoietic development of embryonic stem cells in vitro: cytokine and receptor gene expression. , 1991, Genes & development.
[140] M. Capecchi,et al. Regionally restricted developmental defects resulting from targeted disruption of the mouse homeobox gene hox-1.5 , 1991, Nature.
[141] R. Krumlauf,et al. Introduction of a subtle mutation into the Hox-2.6 locus in embryonic stem cells , 1991, Nature.
[142] G. Wahl,et al. Recombinase-mediated gene activation and site-specific integration in mammalian cells. , 1991, Science.
[143] O. Smithies,et al. Testing an "in-out" targeting procedure for making subtle genomic modifications in mouse embryonic stem cells , 1991, Molecular and cellular biology.
[144] G. Keller,et al. Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture. , 1991, Development.
[145] S. Orkin,et al. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1 , 1991, Nature.
[146] K. Baker,et al. Cardiac Hypertrophy: Mechanical, Neural, and Endocrine Dependence , 1991 .
[147] A. Berns,et al. Consecutive inactivation of both alleles of the pim-1 proto-oncogene by homologous recombination in embryonic stem cells , 1990, Nature.
[148] F. Grosveld,et al. An in vitro globin gene switching model based on differentiated embryonic stem cells. , 1990, Genes & development.
[149] R. Hammer,et al. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β 2m: An animal model of HLA-B27-associated human disorders , 1990, Cell.
[150] D. Wotton,et al. A 3′ transcriptional enhancer regulates tissue‐specific expression of the human CD2 gene. , 1990, The EMBO journal.
[151] J. Seidman,et al. A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutation , 1990, Cell.
[152] S. Solomon,et al. A molecular basis for familial hypertrophic cardiomyopathy: An α β cardiac myosin heavy chain hybrid gene , 1990, Cell.
[153] A. E. Sippel,et al. Tissue specific and position independent expression of the complete gene domain for chicken lysozyme in transgenic mice. , 1990, The EMBO journal.
[154] P. Howles,et al. Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro. , 1990, The Journal of biological chemistry.
[155] N. Henderson,et al. Targeted insertion of exogenous DNA into the eukaryotic genome by the Cre recombinase. , 1990, The New biologist.
[156] D. Ganten,et al. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene , 1990, Nature.
[157] S. Lindquist,et al. The FLP recombinase of yeast catalyzes site-specific recombination in the drosophila genome , 1989, Cell.
[158] M. Capecchi,et al. Altering the genome by homologous recombination. , 1989, Science.
[159] N. Henderson,et al. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[160] M. Capecchi,et al. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells , 1987, Cell.
[161] M. Monk,et al. HPRT-deficient (Lesch–Nyhan) mouse embryos derived from germline colonization by cultured cells , 1987, Nature.
[162] A. Bradley,et al. A potential animal model for Lesch–Nyhan syndrome through introduction of HPRT mutations into mice , 1987, Nature.
[163] P Argos,et al. The integrase family of site‐specific recombinases: regional similarities and global diversity. , 1986, The EMBO journal.
[164] R. Kucherlapati,et al. Insertion of DNA sequences into the human chromosomal β-globin locus by homologous recombination , 1985, Nature.
[165] R Kemler,et al. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. , 1985, Journal of embryology and experimental morphology.
[166] W. Anderson,et al. Prospects for human gene therapy. , 1984, The Journal of reproductive medicine.
[167] K. Abremski,et al. Site-specific recombination by the bacteriophage P1 lox-Cre system. Cre-mediated synapsis of two lox sites. , 1984, Journal of molecular biology.
[168] R. Hoess,et al. Bacteriophage P1 site-specific recombination. Purification and properties of the Cre recombinase protein. , 1984, The Journal of biological chemistry.
[169] R. Hoess,et al. Studies on the properties of P1 site-specific recombination: Evidence for topologically unlinked products following recombination , 1983, Cell.
[170] R. Hoess,et al. P1 site-specific recombination: nucleotide sequence of the recombining sites. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[171] G. Martin,et al. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[172] N. Sternberg,et al. Bacteriophage P1 site-specific recombination. I. Recombination between loxP sites. , 1981, Journal of molecular biology.
[173] M. Kaufman,et al. Establishment in culture of pluripotential cells from mouse embryos , 1981, Nature.
[174] James R. Broach,et al. Replication and recombination functions associated with the yeast plasmid, 2μ circle , 1980, Cell.
[175] E. Giblett,et al. Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. , 1972, Lancet.
[176] G. Ackerman,et al. A phase and electron microscopic study of vasculogenesis and erythropoiesis in the yolk sac of the mouse , 1971, The Anatomical record.
[177] F. Gonzalez-crussi,et al. Vasculogenesis in the chick embryo. An ultrastructural study. , 1971, The American journal of anatomy.
[178] Y. Miura,et al. Tissue interaction and the formation of the first erythroblasts of the chick embryo. , 1969, Developmental biology.
[179] J. Seegmiller,et al. Enzyme Defect Associated with a Sex-Linked Human Neurological Disorder and Excessive Purine Synthesis , 1967, Science.
[180] F. Wilt. Erythropoiesis in the Chick Embryo: The Role of Endoderm , 1965, Science.
[181] G. Ackerman,et al. Vasculogenesis and erythropoiesis in the living yolk sac of the chick embryo a phase microscopic study , 1961, The Anatomical record.
[182] P. Libby. Lesion versus lumen , 1995, Nature Medicine.
[183] K. Rajewsky,et al. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. , 1995, Nucleic acids research.
[184] R. Lefkowitz,et al. Enhanced Myocardial Function inTransgenic Mice Overexpressing theP2-Adrenergic Receptor , 1994 .
[185] R. Ross,et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[186] N. Maeda,et al. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[187] J. Logan,et al. An Isologous Porcine Promoter Permits High Level Expression of Human Hemoglobin in Transgenic Swine , 1994, Bio/Technology.
[188] W. Eyestone,et al. Challenges and progress in the production of transgenic cattle. , 1994, Reproduction, fertility, and development.
[189] N. First,et al. Systems for production of calves from cultured bovine embryonic cells. , 1994, Reproduction, fertility, and development.
[190] C. Whitelaw,et al. Chromosomal position effects and the modulation of transgene expression. , 1994, Reproduction, fertility, and development.
[191] M. Wheeler,et al. Development and validation of swine embryonic stem cells: a review. , 1994, Reproduction, fertility, and development.
[192] A. Dorling,et al. Prospects for xenografting. , 1994, Current opinion in immunology.
[193] K. Chien,et al. Transcriptional regulation during cardiac growth and development. , 1993, Annual review of physiology.
[194] K. Chien,et al. In vivo murine cardiac hypertrophy : a novel model to identify genetic signaling mechanisms that activate an adaptive physiological response , 1993 .
[195] M. Wiles,et al. Hematopoietic commitment during embryonic stem cell differentiation in culture. , 1993, Molecular and cellular biology.
[196] U. Chen,et al. Differentiation of Mouse Embryonic Stem Cells to Lympho-Hematopoietic Lineagesin Vitro , 1992, Developmental immunology.
[197] B. Koller,et al. Altering genes in animals by gene targeting. , 1992, Annual review of immunology.
[198] M. Hooper. Embryonal Stem Cells: Introducing Planned Changes into the Animal Germline , 1992 .
[199] G. Anderson. Isolation and use of embryonic stem cells from livestock species , 1992 .
[200] M. Tavassoli. Embryonic and fetal hemopoiesis: an overview. , 1991, Blood cells.
[201] S. Solomon,et al. A molecular basis for familial hypertrophic cardiomyopathy: an alpha/beta cardiac myosin heavy chain hybrid gene. , 1990, Cell.
[202] M. Perricaudet,et al. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. , 1990, Human gene therapy.
[203] R. Blaese,et al. The ADA human gene therapy clinical protocol: Points to Consider response with clinical protocol, July 6, 1990. , 1990, Human gene therapy.
[204] R. Hoess,et al. The Cre-lox Recombination System , 1990 .
[205] M. Capecchi. The new mouse genetics: altering the genome by gene targeting. , 1989, Trends in genetics : TIG.
[206] E. Robertson. Pluripotential stem cell lines as a route into the mouse germ line , 1986 .
[207] R. Palmiter,et al. Germ-line transformation of mice. , 1986, Annual review of genetics.
[208] F. Sabin. Studies on the origin of blood vessels and of red corpuscles as seen in the living blastoderm of the chick during the second day of incubation , 1920 .